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Abstract
A case of Systemic Sclerosis is hereby reported, with brief review of literature emphasizing the clinical 
characteristics and management. Systemic Sclerosis is a connective tissue disorder affecting the skin, 
blood vessel, and visceral organs. Data relating to the occurrence of scleroderma is sparse or under-
reported in Liberia. This is a case report of a patient suffering from scleroderma seen at the Jackson F. Doe 
Regional Referral Hospital, Tappita, Nimba County, Liberia in May, 2018. The goal was to document the 
clinical occurrence of scleroderma in Liberia. Literature was reviewed using key words including 
scleroderma, sclerosis, Liberia, West Africa. Data bases searched were AJOL and Pubmed. Clinical 
manifestations of systemic scleroderma arise from the diffuse deposition of collagen in the skin and 
visceral organs coupled with vascular injury and immunologic abnormalities. The skin becomes taut 
resulting in claw like appearance of fingers and a mask like appearance of the face. There are associated 
orofacial changes resulting in decrease in facial profile, rigidity of tongue and microstomia. 
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Résumé
Un cas de sclérodermie systémique a été rapporté ; une brève analyse documentaire a mis l'accent sur les 
symptômes de la maladie et son traitement. La sclérodermie systémique est un trouble du tissu conjonctif 
touchant la peau, les vaisseaux sanguins et les organes viscéraux. Au Libéria, les données relatives à 
l'apparition de sclérodermie sont rares ou sous-estimées. Nous vous présentons le cas d'un patient 
souffrant de sclérodermie, observé en mai 2018 à l'hôpital régional Jackson F. Doe de Tappita, dans le 
comté de Nimba, au Libéria. L'objectif était de récolter des données sur la récurrence de la sclérodermie au 
Libéria. Les archives ont été passées en revue, en utilisant des mots clés comme sclérodermie, sclérose, 
Libéria, Afrique de l'ouest. Les bases de données consultées étant AJOL et Pubmeb. Les manifestations 
cliniques de la sclérodermie systémique se traduisent par un dépôt dispersé de collagène sous l'épiderme 
au niveau des organes viscéraux. On ajoute à cela des lésions vasculaires et des anomalies 
immunologiques. La peau est plus tendue, ce qui fait que les doigts s'apparentent à des pinces, et le visage à 
un masque. On assiste donc à une évolution bucco-faciale qui se traduit par une diminution du profil facial, 
une rigidité de la langue et une microstomie. 




1Yale University School of Medicine / Department of Medicine, Jackson F. Doe Regional Referral Hospital / A.M. 
Dogliotti College of Medicine, University of Liberia, Monrovia, Liberia.
2Department of Medicine, Jackson F. Doe Regional Referral Hospital, Tappita, Nimba County, Liberia. 
Received: May 21, 2018     Accepted: June 11, 2018             Published: June 30, 2018
http://orcid.org/0000-0001-6224-1782
Research Journal of Health Sciences subscribed to terms and conditions of Open Access publication. Articles are distributed under the terms of 
Creative Commons Licence (CC BY-NC-ND 4.0). (http://creativecommons.org/licences/by-nc-nd/4.0). 
http://dx.doi.org/10.4314/rejhs.v6i2.7
Systemic sclerosis - case report                                                                           Alebiosu et al.
Res. J. of Health Sci. Vol 6(2), April/June, 2018                                                       100
for localized scleroderma and 33.70 years for 
systemic scleroderma. The Raynaud's syndrome 
was found in 3 of these patients. Adelowo et al. 
found two cases of Raynaud's phenomenon in a 
population of 14 patients (14). This confirms the 
rarity of this phenomenon in Africa (15) probably 
related to the warm tropical climate as it is 
triggered by the cold.
Genetic and environmental factors have 
been implicated as aetiological factors. A first-
degree relative has a high probability of 
developing scleroderma. Environmentally 
induced scleroderma is characterized by the 
generally diffuse distribution of skin sclerosis in 
combination with a history of exposure to an 
agent suspected of precipitating scleroderma. 
Candidate initiating agents include vinyl 
chloride, epoxy resins, pesticides, and a number 
of  o rganic  so lvents  used  in  pa in t s .  
Chemotherapeutic agents including taxanes have 
also been linked to development of scleroderma 
that may resemble that triggered by these other 
agents (16).
Clinically, Scleroderma causes various 
changes at the oral and facial tissues.  The oral 
manifestations of scleroderma include fibrosis 
and rigidity of facial skin giving a mask-like 
appearance of the face. There are also fibrotic 
changes of structures within the mouth including 
the tongue, soft palate, larynx, salivary glands, 
and buccal mucous membrane leading to 
microstomia, dysarthria, dysphagia, and 
xerostomia. Periodontal manifestations 
including a loss of attached gingiva and multiple 
foci of recession may occur (5).The first specific 
clinical sign of scleroderma is the swelling on the 
skin of hands and fingers (17). 
Radiographic changes in scleroderma 
patients are the widening of periodontal space, 
loss of lamina dura, and resorption of the 
mandibular angle (18). The diagnosis of 
scleroderma is clinical and is made by the 
presence of Raynaud's phenomenon, typical skin 
thickening and visceral involvement. Laboratory 
investigations are supportive. The goal of therapy 
is to improve quality of life by minimizing 
specific organ involvement and subsequent life-
threatening disease. Hence, multiple drug 
therapy targeting the different pathogenetic 
mechanisms required.
The aim of this case report is to present 
some characteristics of a patient diagnosed as 
having Systemic Sclerosis and to create 
awareness to the under-reporting of this 
connective tissue disorder in Liberia.
INTRODUCTION
The scleroderma heterogeneous group of 
disorders is linked by the presence of thickened, 
sclerotic skin lesions. The condition is 
characterized by fibrotic changes of the skin, 
blood vessels, and visceral organs (1). 
Scleroderma occurs in two forms, localized and 
systemic forms. In the localized form (morphea), 
there will be involvement of the skin and 
subcutaneous tissue occasionally deeper tissues. 
In the systemic form, diffuse fibrosis of the skin 
and internal organs, primarily involving the 
blood vessels, gastrointestinal tract, lungs, heart, 
and kidneys (1).
Localized scleroderma can be divided 
into linear scleroderma (“en coup de sabre”), and 
localized and generalized morpheae (2). The 
latter are characterized by patches of sclerotic 
skin that develop on the trunk and limbs at sites of 
previously normal texture. Morphea is localized 
scleroderma with involvement of the skin, 
subcutaneous tissue and at times deeper tissues. 
Diffuse fibrosis of the skin and internal organs 
occur in the systemic type, involving the blood 
vessels, gastrointestinal tract, lungs, heart, and 
kidneys. One of the main differences is that 
systemic sclerosis differs from morphea because 
it is accompanied by Raynaud's phenomenon, 
acrosclerosis and internal organ involvement 
(3,4,5). 
Generally, scleroderma is seen in women 
between ages 30 and 50 with a prevalence rate of 
250 per million (3,6).  The incidence varies 
among populations with a report of 3.7 million 
per year in UK and Iceland, whereas, USA has an 
incidence of 18.7-22.8 million per year (7,8,9). 
Scleroderma appears under-reported among 
black Africans and these have mostly been in 
single case reports. The scleroderma in black 
Africa has the same clinical characteristics as 
those described in the literature (9,10,11), but its 
management is hampered in Africa not only due 
to the difficulties of access to care, but also to 
psychological and cultural contexts. Studies have 
confirmed the rarity of report of scleroderma in 
Africa. About the largest case series was from 
South Africa in a case study of 63 blacks living in 
a gold mine region (12).
Keita (13) reported only 35 cases of 
Systemic sclerosis in 10 years in Mali and 
Adelowo (14) in Nigeria had reported 14 cases in 
5 years. Aka et al. in 2016 studied 217 cases of 
scleroderma in Côte d'Ivoire, and reported a 
prevalence of 0.08% in 2015 (15). Patients were 
predominantly women with a sex ratio (F/M) of 
1.66/1. The mean age of patients was 25.35 years 
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 38.6% (Hb = 11.6g/dl).Urinalysis was essentially 
normal as well as the renal function tests. 
(Creatinine = 96.49mmol/l (1.091mg/dl), Urea = 
24.88mg/dl). The chest x-ray (Fig 3) showed 
bilateral lung but predominantly right 
reticulonoduar opacities in keeping with 
interstitial lung disease.
The patient did not carry out certain 
examinations (manometry, cardiac ultrasound 
and immunoassay) for financial reasons. A 
diagnosis of Systemic Sclerosis with secondary 
Sjögren syndrome was made. Patient was 
commenced on Prednisolone and mycophenolate 
1gm bid. 
DISCUSSION
The diagnosis of Systemic Sclerosis is 
mainly clinical and is made by the presence of 
Raynaud's phenomenon, typical skin thickening 
and at times visceral involvement. Laboratory 
investigations are usually supportive. This 48-
year-old lady presented with 12-year history of 
coarseness of the face associated with 
characteristic facie and pigmentary skin changes 
of the trunk as well as deformities of the hands 
and Raynaud phenomenon. 
The patient reported episodes of gastro 
esophageal reflux with heartburn within a year of 
her presentation without dysphagia to solids or 
fluids. It has been reported that 80% of patients 
with scleroderma present with symptoms in 
upper region of the body (19), manifesting as 
dysphagia and gastroesophageal symptoms. 
Others include trismus, decreases in facial 
wrinkles (due to skin fibrosis), orofacial 
telangiectasia and resorption of mandibular 
angle. 
The patient has flexion deformities of the 
lateral three fingers of the right hand, index finger 
of the left hand and there were healed pitted 
ulcers on the fingertips, which deformed the 
digits (Fig 3). Resorption of the terminal 
phalanxes, short and claw-like fingers because of 
acro-osteolisis, ulcers on fingertips are common 
in patients with scleroderma (19,20). 
There was also associated dryness of the 
mouth, associated with gradual reduction in the 
mouth orifice. Xerostomia might be seen in 
scleroderma due to the development of secondary 
Sjögren syndrome (1,3,20). The excessive 
collagen deposition in the cutaneous tissues 
around the mouth causes microstomia, which 
usually prevent the patient from opening and 
closing the mouth. Fibrosis of salivary glands 
leads to xerostomia, dysphagia, and subsequently 
periodontal infections (1, 6). This may lead to 
CASE REPORT
A 48-year-old lady presented to the 
Jackson F Doe Memorial Referral Hospital 
complaining of a 12-year history of coarseness of 
the face, pigmentary skin changes involving the 
trunk associated with smallness and dryness of 
the mouth of four weeks duration. There was 
associated gradual reduction in the mouth orifice. 
There are no difficulty in tongue movement, 
speech, and swallowing. There is no dysphagia to 
solids or fluids. Patient reported episodes of 
gastro esophageal reflux with heartburn on an off 
within a year of presentation. 
There is associated dry persistent cough 
associated with gradual weight loss, but no chest 
pain. There is stiffness of fingers of both hands 
but not the feet, associated pain when the weather 
is cold. No history of joint pain. She has also 
noticed a progressive hoarseness of her voice. 
There is no pruritus, hair changes or changes 
noticed in the eyes. 
There are no changes in the bowel or 
urinary habit. There is no swelling of any part of 
the body including the face. She is neither a 
known hypertensive nor diabetic. Urinary D/N 
ratio is however 6/4, non-frothy. She stopped 
menstruating two years ago. There is no history 
suggestive of thyroid gland dysfunction or 
diabetes mellitus. The past medical, dental, and 
family history was non-contributory.
On general examination patient was 
conscious, co-operative moderately built with no 
signs of pallor. There was no palpably enlarged 
per iphera l  lymphadenopathy.  Fur ther  
examination showed a middle-aged lady with a 
characteristic beaklike facie and microstomia, 
paucity of facial wrinkles and traction alopecia. 
There are decreased number of wrinkles and 
distinct facial features because of the atrophy of 
ala nasi. 
She had hypo and hyper-pigmented 
macules on the trunk, anteriorly and posteriorly 
in a characteristic 'salt-pepper pattern' (Fig 1). 
The skin on the forehead, forearm and the fingers 
were extremely difficult to pick. There were 
flexion deformities of the lateral three fingers of 
the right hand, and the index finger of the left 
hand. There were also healed pitting ulcers on the 
fingertips, which had deformed the digits (Fig 2). 
Vital signs are PR = 100bpm; 144/85mm/Hg, 
O
RR= 18cpm; T=36.5 C. Height = 158cm Weight 
= 49.8kg.
Complete Blood Count was essentially 
3, 
normal – total count of 8.4 x 10 N57.5%, 
L29.1%, M9.4%, E2.71% and B1.3%. Platelets 
3
were 373 x 10 .   The haematocrit was normal at 
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el   al. Epidemiology  of  systemic  lupus  
erythematosus   and  other  connective  tissue  
diseases  in  Rochester,  Minnesota,   1950  
through 1979. Mayo C1in Proc 1985; 60:105- 
113.
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Arthritis Rheum 1997;40:441—445.
10. Laing TJ, Gillepsie  BW, Toth MB et al. Racial 
differences in  scleroderma   among  women   in  
Michigan.   Arthritis   Rheum. 1997; 40:734-742
11. Mayes MD, Lacey N Jr, Beebe-Dimmer J, 
Gillepsie BW, Cooper B, Laing   TJ, 
Scbottenfeld  D.  Prevalence, incidence, survival  
and  disease  characteristics   of  systemic  
sclerosis  in  a large US population. Arthritis 
Rheum 2003;48:2246-2255.
12. Polednak  AP.  Connective   tissue  responses  in  
blacks  in relation to disease: further 
observations. Am J Phys Anthropol 1987;74 
(3):357- 371.
13. Kéita S, Mahé A, Traoré DB. Etude rétrospective 
de 35 cas de sclérodermie systémique à Bamako, 
Mali. Mali Medical 1996;11: 21-27.
14. Adelowo OO, Oguntona S. Scleroderma 
(systemic sclerosis) among Nigerians. Clin 
Rheumatol 2009;28: 1121-1125.
15. BR Aka, A. Diabaté, M. Kaloga, HS Kourouma, 
B.Vagamon, I. Gue. Scleroderma in a Black 
African Subject: A Study of 217 Cases in Cote 
d'Ivoire. J Clin Exp Dermatol Res 2017;8: 398.
16. Itoh M, Yanaba K, Kobayashi T, Nakagawa H. 
Taxane-induced scleroderma. Br J Dermatol 
2007; 156:363.
17. Dedic A, Pasalic A, Hodzic M, Basovic S, Avdic 
M, Pasic E. Scleroderma--from the aspect of 
higher incidence of dental caries.  A high 
occurrence of dental caries as a result of 
zerostomia may be attributed to inadequate oral 
hygiene by virtue of sclerotic changes of the 
hands. 
Systemic Sclerosis is an autoimmune 
disease in which there is no consensus on the 
treatment protocol (3,5,6). In patients who have 
both diffuse cutaneous and visceral involvement, 
the treatment intensity is usually dictated by the 
immunosuppressive therapies used to address 
visceral disease. Unfortunately, most of these 
treatments demonstrate only a modest benefit, at 
best, for skin thickening (2). For patients with 
progressive and diffuse skin involvement who do 
not have visceral involvement, methotrexate 
(MTX) or mycophenolate mofetil (MMF) is 
recommended, ideally therapy should be initiated 
within three years of disease onset (2).  The use of 
cyclophosphamide is reserved for progressive 
skin involvement in patients who are refractory to 
treatment with either MTX or MMF, or have 
severe rapidly progressive skin thickening (2).
For patients with systemic sclerosis refractory to 
treatments, other immune-modulatory agents 
such as intravenous immune globulin (IVIG) or 
rituximab are usually considered as adjuvant 
therapy (2).
There is a substantial increase in the risk 
of mortality in patients with systemic sclerosis. 
Mortality risk is related to presence of pulmonary 
fibrosis, pulmonary arterial hypertension, or 
cardiac causes (2). Other significant causes 
i n c l u d e  r e n a l  d i s e a s e ,  m a l i g n a n c y,  
gastrointestinal, and infectious causes.
In conclusion, Systemic Sclerosis is a 
multisystem organ disorder with oral, cutaneous 
and at times visceral involvement. Physicians 
should be more attentive to the potential risk 
factors for organ damage, particularly very early 
in the disease, even when the patients may not be 
symptomatic. Treatment should be initiated early.
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Figure 1. Shows hypo and hyper-pigmented macules
on the trunk, in a characteristics ‘salt-pepper pattern’.
Figure 2. Shows healed pitting ulcers on the 
finger-tips, with deformed the digits.
Figure 3. Shows bilateral lung (but predominantly
right) reticulonoduar opacities in keeping with 
interstitial lun disease.
Systemic sclerosis - case report                                                                           Alebiosu et al.
Res. J. of Health Sci. Vol 6(2), April/June, 2018                                                       105
